Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7209)
All Articles published online
|
Publishing Process of This Article
|
May 21, 2019 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kuorda H, Abe T, Fujiwara Y, Okamoto T, Yonezawa M, Sato H, Endo K, Oikawa T, Sawara K, Takikawa Y. Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma. World J Gastroenterol 2019; 25(19): 2365-2372 [PMID: 31148907 DOI: 10.3748/wjg.v25.i19.2365] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i19/2365.htm |
| Number | Citing Articles |
| 1 |
Zhiyuan Bo, Bo Chen, Zhengxiao Zhao, Qikuan He, Yicheng Mao, Yunjun Yang, Fei Yao, Yi Yang, Ziyan Chen, Jinhuan Yang, Haitao Yu, Jun Ma, Lijun Wu, Kaiyu Chen, Luhui Wang, Mingxun Wang, Zhehao Shi, Xinfei Yao, Yulong Dong, Xintong Shi, Yunfeng Shan, Zhengping Yu, Yi Wang, Gang Chen. Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study. Clinical Cancer Research 2023; 29(9): 1730 doi: 10.1158/1078-0432.CCR-22-2784
|
| 2 |
Zhiyuan Bo, Jiatao Song, Qikuan He, Bo Chen, Ziyan Chen, Xiaozai Xie, Danyang Shu, Kaiyu Chen, Yi Wang, Gang Chen. Application of artificial intelligence radiomics in the diagnosis, treatment, and prognosis of hepatocellular carcinoma. Computers in Biology and Medicine 2024; 173: 108337 doi: 10.1016/j.compbiomed.2024.108337
|
| 3 |
Martina Catalano, Andrea Casadei-Gardini, Gianmarco Vannini, Claudia Campani, Fabio Marra, Enrico Mini, Giandomenico Roviello. Lenvatinib: established and promising drug for the treatment of advanced hepatocellular carcinoma. Expert Review of Clinical Pharmacology 2021; 14(11): 1353 doi: 10.1080/17512433.2021.1958674
|
| 4 |
Kazuhiro Takahashi, Jaejeong Kim, Amane Takahashi, Shinji Hashimoto, Manami Doi, Kinji Furuya, Ryosuke Hashimoto, Yohei Owada, Koichi Ogawa, Yusuke Ohara, Yoshimasa Akashi, Katsuji Hisakura, Tsuyoshi Enomoto, Osamu Shimomura, Masayuki Noguchi, Tatsuya Oda. Conversion hepatectomy for hepatocellular carcinoma with main portal vein tumour thrombus after lenvatinib treatment: A case report. World Journal of Hepatology 2021; 13(3): 384-392 doi: 10.4254/wjh.v13.i3.384
|
| 5 |
Yu Wang, Baocheng Deng. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. Cancer and Metastasis Reviews 2023; 42(3): 629 doi: 10.1007/s10555-023-10084-4
|
| 6 |
Shohei Komatsu, Yoshihiko Yano, Keitaro Sofue, Masahiro Kido, Motofumi Tanaka, Kaori Kuramitsu, Masahide Awazu, Hidetoshi Gon, Atsushi Yamamoto, Hiroaki Yanagimoto, Hirochika Toyama, Yuzo Kodama, Takamichi Murakami, Takumi Fukumoto. Assessment of lenvatinib treatment for unresectable hepatocellular carcinoma with liver cirrhosis. HPB 2020; 22(10): 1450 doi: 10.1016/j.hpb.2020.03.002
|
| 7 |
Yu Ota, Kazunobu Aso, Hideki Yokoo, Mikihiro Fujiya. Noninvasive Visualization of Tumor Blood Vessels within Hepatocellular Carcinoma by Application of Superb Microvascular Imaging to Contrast-Enhanced Ultrasonography. Diagnostics 2024; 14(7): 678 doi: 10.3390/diagnostics14070678
|
| 8 |
Hugh McGregor, Christopher Brunson, Gregory Woodhead, Abdul Khan, Charles Hennemeyer, Mikin Patel. Quantitative Assessment of the Hemodynamic Effects of Intra-Arterial Nitroglycerin on Hepatocellular Carcinoma using Two-Dimensional Perfusion Angiography. Journal of Vascular and Interventional Radiology 2021; 32(2): 198 doi: 10.1016/j.jvir.2020.10.023
|
| 9 |
Mariella Faccia, Matteo Garcovich, Maria Elena Ainora, Laura Riccardi, Maurizio Pompili, Antonio Gasbarrini, Maria Assunta Zocco. Contrast-Enhanced Ultrasound for Monitoring Treatment Response in Different Stages of Hepatocellular Carcinoma. Cancers 2022; 14(3): 481 doi: 10.3390/cancers14030481
|
| 10 |
Teiji Kuzuya, Masatoshi Ishigami, Takanori Ito, Yoji Ishizu, Takashi Honda, Tetsuya Ishikawa, Mitsuhiro Fujishiro. Favorable radiological antitumor response at 2 weeks after starting lenvatinib for patients with advanced hepatocellular carcinoma. Hepatology Research 2020; 50(3): 374 doi: 10.1111/hepr.13452
|
| 11 |
Naoki Matsumoto, Masahiro Ogawa, Masahiro Kaneko, Shuhei Arima, Mariko Kumagawa, Yukinobu Watanabe, Midori Hirayama, Ryota Masuzaki, Tatsuo Kanda, Mitsuhiko Moriyama. Contrast-enhanced ultrasonography for blood flow detection in hepatocellular carcinoma during lenvatinib therapy. Journal of Medical Ultrasonics 2022; 49(3): 425 doi: 10.1007/s10396-022-01204-8
|
| 12 |
Hiroyuki Suzuki, Hideki Iwamoto, Takashi Niizeki, Shigeo Shimose, Tomotake Shirono, Taizo Yamaguchi, Hirohisa Yano, Yasuji Okuda, Hironori Koga, Takuji Torimura. A long-term survival case of advanced hepatocellular carcinoma treated with multidisciplinary therapies with progression to hepatic arterial infusion chemotherapy and hepatectomy. Kanzo 2020; 61(8): 418 doi: 10.2957/kanzo.61.418
|
| 13 |
Lucia Cerrito, Maria Elena Ainora, Giuseppe Cuccia, Linda Galasso, Irene Mignini, Giorgio Esposto, Matteo Garcovich, Laura Riccardi, Antonio Gasbarrini, Maria Assunta Zocco. Dynamic Contrast-Enhanced Ultrasound in the Prediction of Advanced Hepatocellular Carcinoma Response to Systemic and Locoregional Therapies. Cancers 2024; 16(3): 551 doi: 10.3390/cancers16030551
|
| 14 |
Ernst Michael Jung, Yi Dong. Contrast-Enhanced Ultrasound Imaging of Hepatic Neoplasms. 2021; : 241 doi: 10.1007/978-981-16-1761-4_12
|
| 15 |
Ryo Yano, Masashi Hirooka, Yoshiko Nakamura, Yusuke Imai, Yohei Koizumi, Takao Watanabe, Osamu Yoshida, Yoshio Tokumoto, Masanori Abe, Yoichi Hiasa. A case of hepatocellular carcinoma with pseudoaneurysm formation upon lenvatinib administration. Clinical Journal of Gastroenterology 2024; 17(2): 319 doi: 10.1007/s12328-023-01914-7
|
| 16 |
Shinsuke Uchikawa, Tomokazu Kawaoka, Hatsue Fujino, Atsushi Ono, Takashi Nakahara, Eisuke Murakami, Masami Yamauchi, Daiki Miki, Michio Imamura, Hiroshi Aikata. Evaluation of atezolizumab plus bevacizumab combination therapy for hepatocellular carcinoma using contrast-enhanced ultrasonography. Journal of Medical Ultrasonics 2023; 50(1): 57 doi: 10.1007/s10396-022-01260-0
|
| 17 |
Tetsuya Tachiiri, Hideyuki Nishiofuku, Shinsaku Maeda, Takeshi Sato, Shohei Toyoda, Takeshi Matsumoto, Yuto Chanoki, Kiyoyuki Minamiguchi, Ryosuke Taiji, Hideki Kunichika, Satoshi Yamauchi, Takahiro Ito, Nagaaki Marugami, Toshihiro Tanaka. Vascular Normalization Caused by Short-Term Lenvatinib Could Enhance Transarterial Chemoembolization in Hepatocellular Carcinoma. Current Oncology 2023; 30(5): 4779 doi: 10.3390/curroncol30050360
|
| 18 |
Yi Zhang, Ruiying Zheng, Ming Liu, Xiaoer Zhang, Yueting Sun, Hui Shen, Song Chen, Hongjie Cai, Wenbo Guo, Xiaoyan Xie, Baoxian Liu, Guangliang Huang. Quantitative Parameters of Contrast-Enhanced Ultrasound Predicting the Response to Combined Immune Checkpoint Inhibitor and Anti-angiogenesis Therapies for Unresectable Hepatocellular Carcinoma. Ultrasound in Medicine & Biology 2024; 50(3): 352 doi: 10.1016/j.ultrasmedbio.2023.11.005
|
| 19 |
Yan Zhao, Ya-Ni Zhang, Kai-Ting Wang, Lei Chen. Lenvatinib for hepatocellular carcinoma: From preclinical mechanisms to anti-cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(1): 188391 doi: 10.1016/j.bbcan.2020.188391
|
| 20 |
De-Di Wu, Xiao-Feng He, Chen Tian, Peng Peng, Chuan-Li Chen, Xue-Han Liu, Hua-Jin Pang. Tumor-feeding artery diameter reduction is associated with improved short-term effect of hepatic arterial infusion chemotherapy plus lenvatinib treatment. World Journal of Gastroenterology 2022; 28(26): 3232-3242 doi: 10.3748/wjg.v28.i26.3232
|
| 21 |
Tantawi, MD Mohamed, Liu, MD Ji-Bin, R Eisenbrey, PhD John. Recent Advances in Microbubble-Augmented Cancer Therapy. ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY 2020; 4(3): 155 doi: 10.37015/AUDT.2020.200055
|
| 22 |
Zhi-ting Xu, Hong Ding, Ben-gang Wang, Tian-tian Fu, Yu-li Zhu, Wen-ping Wang, Feng Lin. Savitzky-Golay Filter Based Quantitative Dynamic Contrast-Enhanced Ultrasound on Assessing Therapeutic Response in Mice with Hepatocellular Carcinoma. Journal of Signal Processing Systems 2020; 92(3): 315 doi: 10.1007/s11265-019-01500-6
|
| 23 |
Takeshi Hatanaka, Atsushi Naganuma, Satoru Kakizaki. Lenvatinib for Hepatocellular Carcinoma: A Literature Review. Pharmaceuticals 2021; 14(1): 36 doi: 10.3390/ph14010036
|
| 24 |
Ernst Michael Jung, Yi Dong. Contrast-Enhanced Ultrasound Imaging of Hepatic Neoplasms. 2021; : 251 doi: 10.1007/978-981-16-1761-4_13
|
| 25 |
Shusuke Okamura, Shigeo Shimose, Takashi Niizeki, Naoki Kamachi, Yu Noda, Tomotake Shirono, Hideki Iwamoto, Masahito Nakano, Ryoko Kuromatsu, Hironori Koga, Takuji Torimura. Association between contrast enhancement on contrast‑enhanced CT and lenvatinib effectiveness in hepatocellular carcinoma. Molecular and Clinical Oncology 2021; 16(1) doi: 10.3892/mco.2021.2442
|